샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792742

세계의 나노포어 시퀀싱 시장

Nanopore Sequencing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 575 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

나노포어 시퀀싱 세계 시장은 2030년까지 9억 6,860만 달러에 달할 전망

2024년에 3억 7,880만 달러로 추정되는 나노포어 시퀀싱 세계 시장은 2030년에는 9억 6,860만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 16.9%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 소모품 제공은 CAGR 15.6%를 기록하며 분석 기간 종료시에는 6억 2,420만 달러에 달할 전망입니다. 기기 제공 부문의 성장률은 분석 기간 동안 CAGR 19.8%로 추정됩니다.

미국 시장은 1억 320만 달러로 추정, 중국은 CAGR 22.1%로 성장 예측

미국의 나노포어 시퀀싱 시장은 2024년에 1억 320만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 22.1%로 성장하여 2030년에는 2억 1,120만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 12.7%와 15.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 13.5%로 성장할 것으로 예측됩니다.

세계의 나노포어 시퀀싱 시장 - 주요 동향과 촉진요인 정리

나노포어 시퀀싱이 DNA 및 RNA 분석을 재구성하는 이유는 무엇인가?

나노포어 시퀀싱은 DNA 및 RNA 분자를 실시간으로 분석할 수 있는 빠르고 휴대 가능하며 확장 가능한 방법으로 주목받고 있습니다. 기존의 시퀀싱 플랫폼과 달리 나노포어 기술은 핵산 사슬이 나노포어를 통과할 때 전류의 변화를 측정하여 뉴클레오티드 서열을 검출합니다. 이 접근법은 증폭이나 라벨링이 필요하지 않기 때문에 시료 전처리가 간소화되고 결과를 빠르게 얻을 수 있습니다. 그 결과, 현장 유전자 검사, 감염병 감시, 환경 모니터링, 임상 연구를 위한 귀중한 도구로 등장했습니다.

롱리드 시퀀싱 데이터를 실시간으로 제공할 수 있어 복잡한 구조적 변이 식별, 하프로타입 위상 분석, 전장 전사체 분석에 특히 유용합니다. 연구자들은 유전체 전체 매핑, 후생유전학적 변형 검출, 희귀하거나 시퀀싱이 어려운 생물체 연구에 나노포어 시퀀싱을 점점 더 많이 활용하고 있습니다. 나노포어 디바이스의 컴팩트한 디자인과 휴대성으로 인해 실험실 밖에서 분산형 유전체 분석이 가능해져 현장 조사, 진단, 아웃브레이크 대응에 대한 접근과 활용이 확대되고 있습니다.

기술 개발은 어떻게 정확성과 실용성을 높이고 있는가?

최근 기공 화학, 모터 단백질, 베이스 콜 알고리즘의 발전으로 나노포어 시퀀싱 시스템의 정확도와 처리량이 향상되었습니다. 강화된 나노기공 소재는 보다 일관된 신호 패턴과 더 긴 판독 시간을 제공합니다. 나노기공을 통과하는 핵산의 이동 속도를 조절하는 효소를 업데이트하여 해상도와 판독 품질을 향상시켰습니다. 소프트웨어 레벨에서는 머신러닝 기반의 베이스 콜 툴이 오류율을 지속적으로 감소시키고, 단일 염기 변이 및 메틸화 마크 검출을 가능하게 하고 있습니다.

클라우드 기반 플랫폼과의 통합은 대규모 데이터 처리, 원격 액세스, 공동 분석을 지원합니다. 플로우셀 설계와 멀티플렉스 기능의 향상으로 연구자들은 더 적은 비용으로 더 많은 샘플을 한 번에 시퀀싱할 수 있게 되었습니다. 모듈형 시퀀싱 키트는 복잡한 전처리 없이 분해 샘플, 메타유전체 혼합물, 직접 RNA 사슬 등 다양한 입력에 대응할 수 있게 되었습니다. 이러한 개선을 통해 이 기술은 더 많은 연구자들이 보다 폭넓게 사용할 수 있는 다재다능하고 사용하기 쉬운 기술로 거듭났습니다.

나노포어 시퀀싱의 적용을 촉진하고 있는 분야와 사용 사례는 무엇인가?

학술 연구기관은 유전체, 후생유전학, 미생물학, 진화론 연구에서의 유용성 때문에 나노포어 시퀀싱을 일찍이 채택하고 있습니다. 임상 실험실에서는 신속한 병원체 식별, 항균제 내성 프로파일링, 유전병 스크리닝에 사용됩니다. 종양학에서는 종양 프로파일링, 융합 유전자 검출, 전사체 분석을 지원합니다. 농업 분야에서는 작물 유전체 분석, 토양 마이크로바이옴 프로파일링, 동물 건강 모니터링에 활용되고 있습니다.

현장 기반 애플리케이션은 주요 성장 분야입니다. 공중 보건 기관은 저자원 및 원격지에서의 병원체 추적을 포함한 실시간 발병 모니터링을 위해 나노포어 플랫폼을 도입하고 있습니다. 야생동물 연구자와 자연보호 활동가들은 생물 다양성 조사 및 종 식별에 활용하고 있습니다. 비용이 낮아지고 사용자 인터페이스가 더 쉽게 사용할 수 있게 됨에 따라 소규모 실험실과 현장 진료소에서 분산형 검사 및 조기 진단을 위해 나노포어 기반 도구가 연구되고 있습니다.

나노포어 시퀀싱 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다....

나노포어 시퀀싱 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 신속, 실시간, 긴 리드 시퀀싱 기술에 대한 수요는 연구 및 임상 분야에서 시퀀싱 기술의 지속적인 채택을 뒷받침하고 있습니다. 베이스 콜 정확도, 효소 화학, 신호 처리의 발전으로 신뢰성을 높이고 유용성을 확대. 저렴한 가격의 휴대용 시퀀싱 디바이스의 확대로 원격지, 모바일, 분산형 환경에서의 사용을 촉진합니다. 맞춤형 의료, 감염병 감시, 직접 RNA 시퀀싱에 대한 관심이 높아짐에 따라 애플리케이션 개발이 더욱 가속화될 것입니다. 바이오인포매틱스 플랫폼 및 클라우드 서비스와의 통합을 통해 효율적인 데이터 분석 및 공유를 촉진합니다. 학술 기관, 의료 시스템, 정부의 투자는 도입과 혁신 파이프라인의 확장에 기여하고 있습니다.

부문

제공 분야(소모품, 기기), 시퀀싱 유형(직류, 합성 DNA&수평 터널 전류, 광학적 판독 기술, 엑소뉴클레아제), 나노포어 유형(솔리드 스테이트 나노포어, 바이오로지카르나노포아, 하이브리드 나노포어), 용도(인간 유전학 용도, 임상 연구 용도, 식물 연구 용도, 미생물학 용도, 기타 용도), 최종 용도(바이오테크놀러지 기업 최종 용도, 임상 연구소 최종 용도, 학술·연구기관 최종 용도)

조사 대상 기업 사례

  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • CD-Genomics
  • Electronic Biosciences, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Genia Technologies(Roche subsidiary)
  • Illumina, Inc.
  • INanoBio Inc.
  • Nanopore Technologies plc(Oxford)
  • Nabsys, Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Stratos Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Danaher Corporation(Beckman Coulter)
  • Myriad Genetics, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.25

Global Nanopore Sequencing Market to Reach US$968.6 Million by 2030

The global market for Nanopore Sequencing estimated at US$378.8 Million in the year 2024, is expected to reach US$968.6 Million by 2030, growing at a CAGR of 16.9% over the analysis period 2024-2030. Consumables Offering, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$624.2 Million by the end of the analysis period. Growth in the Instruments Offering segment is estimated at 19.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$103.2 Million While China is Forecast to Grow at 22.1% CAGR

The Nanopore Sequencing market in the U.S. is estimated at US$103.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$211.2 Million by the year 2030 trailing a CAGR of 22.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.7% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.5% CAGR.

Global Nanopore Sequencing Market - Key Trends & Drivers Summarized

Why Is Nanopore Sequencing Reshaping DNA and RNA Analysis?

Nanopore sequencing is gaining attention as a fast, portable, and scalable method for analyzing DNA and RNA molecules in real time. Unlike traditional sequencing platforms, nanopore technology detects nucleotide sequences by measuring changes in electrical current as a nucleic acid strand passes through a nanopore. This approach does not require amplification or labeling, which simplifies sample preparation and speeds up results. As a result, it has emerged as a valuable tool for on-site genetic testing, infectious disease surveillance, environmental monitoring, and clinical research.

Its ability to deliver long-read sequencing data in real time makes it especially useful for identifying complex structural variations, haplotype phasing, and full-length transcript analysis. Researchers are increasingly adopting nanopore sequencing to map entire genomes, detect epigenetic modifications, and study rare or hard-to-sequence organisms. The compact design and portability of nanopore devices allow for decentralized genomic analysis outside laboratory settings, broadening access and use in field research, diagnostics, and outbreak response.

How Are Technology Developments Enhancing Accuracy and Utility?

Recent advances in pore chemistry, motor proteins, and basecalling algorithms have improved the accuracy and throughput of nanopore sequencing systems. Enhanced nanopore materials provide more consistent signal patterns and longer reading durations. Updated enzymes that control the translocation speed of nucleic acids through the nanopore offer better resolution and read quality. At the software level, machine learning-based basecalling tools continue to reduce error rates and enable detection of single-nucleotide variants and methylation marks.

Integration with cloud-based platforms supports large-scale data processing, remote access, and collaborative analysis. Improvements in flow cell design and multiplexing capabilities allow researchers to sequence more samples per run at lower cost. Modular sequencing kits now accommodate a wide range of inputs, including degraded samples, metagenomic mixtures, or direct RNA strands, without the need for complex pre-processing. These improvements are making the technology more versatile and user-friendly for a broader research audience.

Which Sectors and Use Cases Are Driving Adoption of Nanopore Sequencing?

Academic research institutions remain early adopters of nanopore sequencing due to its utility in genomics, epigenetics, microbiology, and evolutionary studies. Clinical laboratories use it for rapid pathogen identification, antimicrobial resistance profiling, and genetic disease screening. In oncology, it supports tumor profiling, fusion gene detection, and transcriptomic analysis. The agricultural sector leverages the technology for crop genome analysis, soil microbiome profiling, and animal health monitoring.

Field-based applications are a key growth area. Public health agencies deploy nanopore platforms for real-time outbreak monitoring, including pathogen tracking in low-resource or remote settings. Wildlife researchers and conservationists use it for biodiversity studies and species identification. As costs decline and user interfaces become more accessible, small laboratories and point-of-care settings are exploring nanopore-based tools for decentralized testing and early diagnostics.

Growth in the Nanopore Sequencing Market Is Driven by Several Factors…

Growth in the nanopore sequencing market is driven by several factors. Demand for rapid, real-time, and long-read sequencing technologies supports continued adoption across research and clinical sectors. Advances in basecalling accuracy, enzyme chemistry, and signal processing enhance reliability and broaden utility. Expansion of low-cost, portable sequencing devices encourages use in remote, mobile, and decentralized environments. Growing interest in personalized medicine, infectious disease surveillance, and direct RNA sequencing further accelerates application development. Integration with bioinformatics platforms and cloud services facilitates efficient data analysis and sharing. Investments from academic institutions, healthcare systems, and governments contribute to expanding adoption and innovation pipelines.

SCOPE OF STUDY:

The report analyzes the Nanopore Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Consumables Offering, Instruments Offering); Sequencing Type (Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique, Exonuclease); Nanopore Type (Solid State Nanopore, Biological Nanopore, Hybrid Nanopore); Application (Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application, Other Applications); End-Use (Biotechnology Companies End-Use, Clinical Laboratories End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • CD-Genomics
  • Electronic Biosciences, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Genia Technologies (Roche subsidiary)
  • Illumina, Inc.
  • INanoBio Inc.
  • Nanopore Technologies plc (Oxford)
  • Nabsys, Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Stratos Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Danaher Corporation (Beckman Coulter)
  • Myriad Genetics, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Nanopore Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Real-Time and Portable Genomic Sequencing Drives Adoption of Nanopore Technology
    • Ability to Directly Read Long DNA and RNA Strands Throws Spotlight on Nanopore Unique Technical Advantage
    • Rise in Infectious Disease Surveillance and Variant Tracking Fuels Application in Pathogen Genomics
    • Rapid Turnaround Time and Minimal Sample Preparation Promote Use in Clinical and Field Settings
    • Expansion of Precision Medicine and Genetic Diagnostics Strengthens Business Case for On-Site Sequencing
    • OEM Investment in Miniaturized and Scalable Sequencing Devices Enhances Accessibility Across Use Cases
    • Advancements in Base Calling Accuracy and Error Correction Support Broader Scientific Acceptance
    • Growth in Agricultural Genomics and Environmental DNA Monitoring Boosts Utility in Non-Clinical Markets
    • Open Data Platforms and User-Driven Bioinformatics Tools Promote Community Engagement in Nanopore Research
    • Integration With AI-Based Analytics Enhances Interpretation of Complex Genomic Datasets
    • Surge in Cancer Genomics and Liquid Biopsy Research Encourages High-Resolution Sequencing Tools
    • Portability of Nanopore Devices Enables Sequencing in Remote, Resource-Limited, and Emergency Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nanopore Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Human Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Human Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Human Genetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinical Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plant Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plant Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Plant Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Microbiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Microbiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Microbiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Direct Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Direct Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Direct Current by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Optical Reading Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Optical Reading Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Optical Reading Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Exonuclease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Exonuclease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Exonuclease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Solid State Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Solid State Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Solid State Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Biological Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Biological Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Biological Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Hybrid Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Hybrid Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Hybrid Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • JAPAN
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Japan 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • CHINA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 101: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: China 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: China 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • EUROPE
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Nanopore Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Europe 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Europe 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 131: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Europe Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Europe 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • FRANCE
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 134: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: France 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: France 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: France 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 146: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: France Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: France 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • GERMANY
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Germany 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Germany 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Germany 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Germany 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 161: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Germany Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Germany 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Italy 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Italy 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Italy 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Italy 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 176: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Italy Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Italy 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 179: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: UK 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: UK 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 185: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: UK 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UK 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 191: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UK Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UK 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 194: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Spain Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Spain 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 197: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Spain Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Spain 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Spain Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Spain 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 203: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Spain Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Spain 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 206: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Spain Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Spain 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 209: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Russia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Russia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 212: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Russia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Russia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 215: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Russia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Russia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 218: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Russia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Russia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 221: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Russia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Russia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Europe Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Europe Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Europe 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Europe Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Europe Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for Nanopore Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Asia-Pacific Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Asia-Pacific Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Asia-Pacific Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Asia-Pacific Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 257: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Australia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Australia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 260: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Australia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Australia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 263: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Australia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Australia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 266: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Australia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Australia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 269: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Australia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Australia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • INDIA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 272: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: India Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: India 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 275: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: India Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: India 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 278: India Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: India Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: India 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: India Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: India 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 284: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: India Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: India 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 287: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: South Korea Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: South Korea 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 290: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: South Korea Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: South Korea 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 293: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: South Korea Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: South Korea 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 296: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: South Korea Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: South Korea 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 299: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: South Korea Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: South Korea 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 317: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 318: Latin America Historic Review for Nanopore Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Latin America 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 320: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Latin America Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Latin America 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 323: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Latin America Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Latin America 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 326: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Latin America Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Latin America 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 329: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Latin America Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Latin America 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 332: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Latin America Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Latin America 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 335: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Argentina Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Argentina 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 338: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Argentina Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Argentina 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 341: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Argentina Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Argentina 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 344: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Argentina Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Argentina 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 347: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Argentina Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Argentina 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 350: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Brazil Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Brazil 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 353: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Brazil Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Brazil 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 356: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Brazil Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Brazil 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 359: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Brazil Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Brazil 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 362: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Brazil Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Brazil 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 365: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Mexico Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Mexico 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 368: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Mexico Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Mexico 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 371: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Mexico Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Mexico 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 374: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Mexico Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Mexico 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 377: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Mexico Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Mexico 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Latin America Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Latin America Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Latin America Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Latin America Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Latin America Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 395: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 396: Middle East Historic Review for Nanopore Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: Middle East 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 398: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Middle East Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: Middle East 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 401: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Middle East Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: Middle East 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 404: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Middle East Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Middle East 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 407: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Middle East Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Middle East 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 410: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Middle East Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Middle East 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 413: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Iran Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Iran 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 416: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Iran Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 418: Iran 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 419: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Iran Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 421: Iran 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 422: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Iran Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 424: Iran 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 425: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Iran Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 427: Iran 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 428: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Israel Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 430: Israel 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 431: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 432: Israel Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 433: Israel 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 434: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 435: Israel Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 436: Israel 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 437: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 438: Israel Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 439: Israel 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 440: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 441: Israel Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 442: Israel 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 444: Saudi Arabia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 445: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 447: Saudi Arabia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 448: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 450: Saudi Arabia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 451: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 453: Saudi Arabia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 454: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 456: Saudi Arabia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 457: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 458: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 459: UAE Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 460: UAE 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 461: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 462: UAE Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 463: UAE 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 464: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 465: UAE Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 466: UAE 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 467: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 468: UAE Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 469: UAE 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 470: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 471: UAE Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 472: UAE 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 474: Rest of Middle East Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 475: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 477: Rest of Middle East Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 478: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 480: Rest of Middle East Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 481: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 483: Rest of Middle East Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 484: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 486: Rest of Middle East Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 487: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • AFRICA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 488: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 489: Africa Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 490: Africa 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 491: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 492: Africa Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 493: Africa 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 494: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 495: Africa Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 496: Africa 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 497: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 498: Africa Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 499: Africa 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 500: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 501: Africa Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 502: Africa 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제